工程特定的人类iPS记者细胞系产生光遗传修饰的光受体
Elise Léger-Charnay1, Amélie Slembrouck-Brec1, Olivier Goureau2
1Institut de la Vision, Sorbonne Université, INSERM UMR_S968, CNRS UMR 7210, Paris, France.
Advances in experimental medicine and biology
|February 10, 2025
概括
这项研究工程诱导多能干细胞 (iPSCs) 用于细胞疗法治疗失明. 修改后的细胞表达了一种对光敏感的蛋白质,使视力恢复能够独立于自然光受体的发育.
科学领域:
- 眼科医生 眼科 眼科
- 神经科学是一个神经科学.
- 生物技术是生物技术.
背景情况:
- 光受体退行性疾病导致视力丧失.
- 目前用于这些疾病的细胞疗法需要移植的细胞完全成熟,形成外部细分并与视网膜色素表皮 (RPE) 集成.
- 这种成熟过程是成功移植细胞的重要障碍.
研究的目的:
- 开发一种用于光受体退行性疾病的新型细胞治疗方法.
- 通过赋予移植细胞的光敏感性来克服传统细胞疗法的局限性.
- 创建基因工程诱导多能干细胞 (iPSCs) 用于光遗传视力恢复.
主要方法:
- 在AAVS1位点利用CRISPR/Cas9基因编辑,将爪微生物素基因插入iPSC基因组.
- 在特定的光受体促进剂下,设计iPSC来表达红光敏感的化物Jaws.
- 创建并验证了一个敲进的Jaws-EGFP iPSC系列,证实了它的干性和多能性.
主要成果:
- 成功生成了一条稳定的iPSC线,该线被设计为表达下巴-EGFP融合蛋白.
- 验证了工程 iPSC 的多能性和干性.
- 工程细胞被准备分化成光受体用于移植.
结论:
- 对iPSC衍生光受体的光遗传修饰为治疗失明提供了一个有前途的策略.
- 这种方法绕过了成熟的外段形成和RPE接触的需要,以获得光敏感度.
- 进一步的研究将评估这些工程细胞在动物模型中恢复视力的有效性.
相关概念视频
01:13Induced Pluripotent Stem Cells
23.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
23.0K
02:11Reporter Genes
11.4K
Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
11.4K
01:06Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K
01:29Somatic to iPS Cell Reprogramming
2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
01:22iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
01:21EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K